shadow_tr

Hepatitis C (HCV)

LiverChronic hepatitis C is a viral infection which can lead to serious liver disorders such as cirrhosis and liver cancer. Today HCV is the leading cause of liver failure requiring transplantation in the United States. Despite what is commonly written in the media, HCV is curable in many patients. Currently treatments involve antiviral medications for up to 6-12 months with close physician follow up. Blood tests are used to monitor progress and safety. A liver biopsy may be suggested to guide treatment decisions. The Gastroenterology and Hepatology section is involved in cutting edge research of this disease and is proud to offer our patients the most innovative and effective treatment regimens delivered by a well-trained, talented and compassionate team of individuals. In many instances patients have the opportunity to receive treatment in multicenter randomized trials testing new, more effective, shorter, and less toxic medications. We also have unparalled expertise in treating more advanced and complicated cases.

For more information please call 504-988-5344

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu